These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23934254)

  • 1. On-command drug release from nanochains inhibits growth of breast tumors.
    Peiris PM; Tam M; Vicente P; Abramowski A; Toy R; Bauer L; Mayer A; Pansky J; Doolittle E; Tucci S; Schmidt E; Shoup C; Rao S; Murray K; Gopalakrishnan R; Keri RA; Basilion JP; Griswold MA; Karathanasis E
    Pharm Res; 2014 Jun; 31(6):1460-8. PubMed ID: 23934254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model.
    Alibolandi M; Sadeghi F; Abnous K; Atyabi F; Ramezani M; Hadizadeh F
    Eur J Pharm Biopharm; 2015 Aug; 94():521-31. PubMed ID: 26170161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The release of Doxorubicin from liposomes monitored by MRI and triggered by a combination of US stimuli led to a complete tumor regression in a breast cancer mouse model.
    Rizzitelli S; Giustetto P; Faletto D; Delli Castelli D; Aime S; Terreno E
    J Control Release; 2016 May; 230():57-63. PubMed ID: 27049069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of thermal dose on heat shock protein expression after radio-frequency ablation with and without adjuvant nanoparticle chemotherapies.
    Moussa M; Goldberg SN; Kumar G; Levchenko T; Torchilin V; Ahmed M
    Int J Hyperthermia; 2016 Dec; 32(8):829-841. PubMed ID: 27600101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined radiofrequency ablation and adjuvant liposomal chemotherapy: effect of chemotherapeutic agent, nanoparticle size, and circulation time.
    Ahmed M; Lukyanov AN; Torchilin V; Tournier H; Schneider AN; Goldberg SN
    J Vasc Interv Radiol; 2005 Oct; 16(10):1365-71. PubMed ID: 16221908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetophoretic Delivery of a Tumor-Priming Agent for Chemotherapy of Metastatic Murine Breast Cancer.
    Park J; Park J; Castanares MA; Collins DS; Yeo Y
    Mol Pharm; 2019 May; 16(5):1864-1873. PubMed ID: 30916974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced delivery of chemotherapy to tumors using a multicomponent nanochain with radio-frequency-tunable drug release.
    Peiris PM; Bauer L; Toy R; Tran E; Pansky J; Doolittle E; Schmidt E; Hayden E; Mayer A; Keri RA; Griswold MA; Karathanasis E
    ACS Nano; 2012 May; 6(5):4157-68. PubMed ID: 22486623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved antitumor activity and reduced toxicity of doxorubicin encapsulated in poly(ε-caprolactone) nanoparticles in lung and breast cancer treatment: An in vitro and in vivo study.
    Cabeza L; Ortiz R; Prados J; Delgado ÁV; Martín-Villena MJ; Clares B; Perazzoli G; Entrena JM; Melguizo C; Arias JL
    Eur J Pharm Sci; 2017 May; 102():24-34. PubMed ID: 28219748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive Imaging of Liposomal Delivery of Superparamagnetic Iron Oxide Nanoparticles to Orthotopic Human Breast Tumor in Mice.
    Kato Y; Zhu W; Backer MV; Neoh CC; Hapuarachchige S; Sarkar SK; Backer JM; Artemov D
    Pharm Res; 2015 Nov; 32(11):3746-3755. PubMed ID: 26078000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of cancer micrometastasis using a multicomponent chain-like nanoparticle.
    Peiris PM; Toy R; Abramowski A; Vicente P; Tucci S; Bauer L; Mayer A; Tam M; Doolittle E; Pansky J; Tran E; Lin D; Schiemann WP; Ghaghada KB; Griswold MA; Karathanasis E
    J Control Release; 2014 Jan; 173():51-8. PubMed ID: 24188960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxorubicin-loaded nanocarriers: A comparative study of liposome and nanostructured lipid carrier as alternatives for cancer therapy.
    Fernandes RS; Silva JO; Monteiro LOF; Leite EA; Cassali GD; Rubello D; Cardoso VN; Ferreira LAM; Oliveira MC; de Barros ALB
    Biomed Pharmacother; 2016 Dec; 84():252-257. PubMed ID: 27664949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Invasive Brain Tumors Using a Chain-like Nanoparticle.
    Peiris PM; Abramowski A; Mcginnity J; Doolittle E; Toy R; Gopalakrishnan R; Shah S; Bauer L; Ghaghada KB; Hoimes C; Brady-Kalnay SM; Basilion JP; Griswold MA; Karathanasis E
    Cancer Res; 2015 Apr; 75(7):1356-65. PubMed ID: 25627979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant liposomal doxorubicin markedly affects radiofrequency ablation-induced effects on periablational microvasculature.
    Moussa M; Goldberg SN; Tasawwar B; Sawant RR; Levchenko T; Kumar G; Torchilin VP; Ahmed M
    J Vasc Interv Radiol; 2013 Jul; 24(7):1021-33. PubMed ID: 23664809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved drug delivery and therapeutic efficacy of PEgylated liposomal doxorubicin by targeting anti-HER2 peptide in murine breast tumor model.
    Zahmatkeshan M; Gheybi F; Rezayat SM; Jaafari MR
    Eur J Pharm Sci; 2016 Apr; 86():125-35. PubMed ID: 26972276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraductally administered pegylated liposomal doxorubicin reduces mammary stem cell function in the mammary gland but in the long term, induces malignant tumors.
    Chun YS; Yoshida T; Mori T; Huso DL; Zhang Z; Stearns V; Perkins B; Jones RJ; Sukumar S
    Breast Cancer Res Treat; 2012 Aug; 135(1):201-8. PubMed ID: 22752247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histoplasty Modification of the Tumor Microenvironment in a Murine Preclinical Model of Breast Cancer.
    Pieper AA; Stowe NA; Periyasamy S; Burkel BM; Tsarovsky NW; Singh AP; Rakhmilevich AL; Sondel PM; Ponik SM; Laeseke PF; Yu JJ
    J Vasc Interv Radiol; 2024 Jun; 35(6):900-908.e2. PubMed ID: 38508448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Na
    Araste F; Abnous K; Hashemi M; Dehshahri A; Detampel P; Alibolandi M; Ramezani M
    Eur J Pharm Sci; 2020 Feb; 143():105207. PubMed ID: 31870814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation.
    Alibolandi M; Abnous K; Sadeghi F; Hosseinkhani H; Ramezani M; Hadizadeh F
    Int J Pharm; 2016 Mar; 500(1-2):162-78. PubMed ID: 26802496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous tumor ablation: reduced tumor growth with combined radio-frequency ablation and liposomal doxorubicin in a rat breast tumor model.
    D'Ippolito G; Ahmed M; Girnun GD; Stuart KE; Kruskal JB; Halpern EF; Goldberg SN
    Radiology; 2003 Jul; 228(1):112-8. PubMed ID: 12808127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous tumor ablation: increased necrosis with combined radio-frequency ablation and intravenous liposomal doxorubicin in a rat breast tumor model.
    Goldberg SN; Girnan GD; Lukyanov AN; Ahmed M; Monsky WL; Gazelle GS; Huertas JC; Stuart KE; Jacobs T; Torchillin VP; Halpern EF; Kruskal JB
    Radiology; 2002 Mar; 222(3):797-804. PubMed ID: 11867804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.